Patent Assignment
Reel/Frame 043067/0567
Change of Name
Recorded: 2017-07-21
Pages: 2
Assignor
TEKMIRA PHARMACEUTICALS CORPORATION
Executed: 2015-07-31
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Lipid Formulation
Application:
15/187,633 →
Publication:
US 2017/0143631
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 21, 2017
From: CHEN, JIANXIN; ANSELL, STEVEN; AKINC, AKIN; DORKIN, JOSEPH ROBERT
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 043067/0523 →
Assignment of Assignor's Interest
Jul 21, 2017
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 043067/0555 →
Merger and Change of Name
Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →